Orexo's Finance Chief Plans Exit in December

01:06 AM EDT, 09/02/2026 (MT Newswires) -- Orexo (ORX.ST) Chief Financial Officer Fredrik Järrsten stepped down to pursue another opportunity at medical technologies-focused investment company Segulah Medical Acceleration. Järrsten will remain with the Swedish pharmaceutical company until December to support ongoing organizational restructuring and financing activities, according to a Tuesday release.